Evidence map›Paper›PMID 35883740›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Comparative Assessment of the Antioxidant and Anticancer Activities of

Enas E Eltamany, Marwa S Goda, Mohamed S Nafie, Abdelghafar M Abu-Elsaoud, Rawan H Hareeri, Mohammed M Aldurdunji, Sameh S Elhady, Jihan M Badr, Nermeen A Eltahawy

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Ferulic andRSC advances · 2026
    Article
  2. Article
  3. Click synthesis of some novel benzo[RSC medicinal chemistry · 2025
    Article
  4. [Application ofZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  5. Article
  6. Review
  7. Plant Metabolomics: The Future of Anticancer Drug Discovery.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  8. Article
  9. Future medicinal chemistry · 2024
    Article
  10. Review
  11. Exploration of the Antioxidant and Anti-inflammatory Potential ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  12. Anti-Frontiers in microbiology · 2023
    Article
  13. Comparative Cytotoxic Evaluation ofPharmaceuticals (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Enas E EltamanyDepartment of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.ORCID 0000-0003-1607-4285
Marwa S GodaDepartment of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.ORCID 0000-0001-9291-8940
Mohamed S NafieDepartment of Chemistry, Faculty of Science, Suez Canal University, Ismailia 41522, Egypt.ORCID 0000-0003-4454-6390
Abdelghafar M Abu-ElsaoudDepartment of Botany and Microbiology, Faculty of Science, Suez Canal University, Ismailia 41522, Egypt.ORCID 0000-0002-6269-3418
Rawan H HareeriDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Mohammed M AldurdunjiDepartment of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, P.O. Box 13578, Makkah 21955, Saudi Arabia.
Sameh S ElhadyDepartment of Natural Products, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-3799-0581
Jihan M BadrDepartment of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.
Nermeen A EltahawyDepartment of Pharmacognosy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.
Suez Canal University · EGKing Abdulaziz University · SAUmm al-Qura University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study presents a comparison between two mistletoe plants-

Indexed as

anticancerantioxidantchemical profilingdocking studiesdrug discoveryindustrial developmentP. acaciaP. curviflorus

Identifiers

PMID35883740
PMCPMC9311546
OpenAlexW4283463288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.